Sale!

PURA Gene Mental Retardation Autosomal Dominant Type 31 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PURA gene mental retardation autosomal dominant type 31 genetic test is a specialized diagnostic procedure designed to identify mutations in the PURA gene, which have been associated with a rare form of intellectual disability known as mental retardation, autosomal dominant type 31. This condition is characterized by developmental delays, intellectual challenges, and in some cases, physical abnormalities and neurological issues. The test is crucial for early diagnosis, which can significantly aid in the management and treatment of the condition, potentially improving the quality of life for those affected.

Performed at DNA Labs UAE, a leading genetic testing facility, this test offers a comprehensive analysis of the PURA gene to detect any abnormalities that may indicate the presence of the disorder. The cost of the test is set at 4400 AED, reflecting the intricate technology and expertise required to conduct such a specialized genetic analysis. By choosing DNA Labs UAE for this test, patients and healthcare providers can expect high-quality services, accurate results, and the support needed to understand and manage the implications of the findings.

Description

PURA Gene Mental Retardation Autosomal Dominant Type 31 Genetic Test

Test Name: PURA Gene Mental retardation autosomal dominant type 31 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for PURA Gene Mental retardation, autosomal dominant type 31 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PURA Gene Mental retardation, autosomal dominant type 31.

Test Details: The PURA gene is associated with a condition called mental retardation, autosomal dominant type 31 (MRD31). MRD31 is a genetic disorder characterized by intellectual disability and developmental delay. It is inherited in an autosomal dominant manner, which means that a person only needs to inherit one copy of the mutated gene from either parent to develop the condition.

NGS (Next-Generation Sequencing) is a type of genetic testing that uses advanced sequencing technologies to rapidly and efficiently analyze multiple genes simultaneously. NGS genetic testing can identify mutations or variations in the PURA gene that may be responsible for MRD31.

The purpose of the PURA gene NGS genetic test is to diagnose individuals with MRD31 by detecting any mutations or variations in the PURA gene. This information can help healthcare professionals provide appropriate medical management, genetic counseling, and support to affected individuals and their families.

It is important to consult with a healthcare professional or a genetic counselor to understand the benefits, limitations, and implications of undergoing the PURA gene NGS genetic test. They can provide detailed information about the test, its accuracy, and the potential impact of the results on the individual and their family.

Test Name	PURA Gene Mental retardation autosomal dominant type 31 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for PURA Gene Mental retardation, autosomal dominant type 31 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PURA Gene Mental retardation, autosomal dominant type 31
Test Details	The PURA gene is associated with a condition called mental retardation, autosomal dominant type 31 (MRD31). MRD31 is a genetic disorder characterized by intellectual disability and developmental delay. It is inherited in an autosomal dominant manner, which means that a person only needs to inherit one copy of the mutated gene from either parent to develop the condition. NGS (Next-Generation Sequencing) is a type of genetic testing that uses advanced sequencing technologies to rapidly and efficiently analyze multiple genes simultaneously. NGS genetic testing can identify mutations or variations in the PURA gene that may be responsible for MRD31. The purpose of the PURA gene NGS genetic test is to diagnose individuals with MRD31 by detecting any mutations or variations in the PURA gene. This information can help healthcare professionals provide appropriate medical management, genetic counseling, and support to affected individuals and their families. It is important to consult with a healthcare professional or a genetic counselor to understand the benefits, limitations, and implications of undergoing the PURA gene NGS genetic test. They can provide detailed information about the test, its accuracy, and the potential impact of the results on the individual and their family.